LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 56.71 | 770.25 | 4156 | 8001 | 0.5194 | 0.6473 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 56.71 | 770.25 | 3586 | 8001 | 0.4482 | 0.5769 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.94 | 770.25 | 4348 | 8444 | 0.5149 | 0.6504 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 58.94 | 770.25 | 3798 | 8444 | 0.4498 | 0.5870 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.16 | 770.25 | 4492 | 8892 | 0.5052 | 0.6482 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 61.16 | 770.25 | 3982 | 8892 | 0.4478 | 0.5928 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.39 | 770.25 | 4691 | 9326 | 0.5030 | 0.6523 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 63.39 | 770.25 | 4138 | 9326 | 0.4437 | 0.5957 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.61 | 770.25 | 4897 | 9736 | 0.5030 | 0.6576 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 65.61 | 770.25 | 4349 | 9736 | 0.4467 | 0.6047 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.83 | 770.25 | 5067 | 10078 | 0.5028 | 0.6616 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 67.83 | 770.25 | 4508 | 10078 | 0.4473 | 0.6101 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.05 | 770.25 | 5160 | 10413 | 0.4955 | 0.6591 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 70.05 | 770.25 | 4662 | 10413 | 0.4477 | 0.6148 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.27 | 770.25 | 5328 | 10730 | 0.4965 | 0.6635 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.27 | 770.25 | 4834 | 10730 | 0.4505 | 0.6214 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.50 | 770.25 | 5477 | 10991 | 0.4983 | 0.6678 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.50 | 770.25 | 5013 | 10991 | 0.4561 | 0.6298 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.75 | 770.25 | 5642 | 11262 | 0.5009 | 0.6729 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 76.75 | 770.25 | 5142 | 11262 | 0.4565 | 0.6332 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.98 | 770.25 | 5750 | 11518 | 0.4992 | 0.6738 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 78.98 | 770.25 | 5265 | 11518 | 0.4571 | 0.6365 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.20 | 770.25 | 5946 | 11766 | 0.5053 | 0.6814 | MN20160304_L02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.20 | 770.25 | 5400 | 11766 | 0.4589 | 0.6407 | MN20160304_L02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 83.42 | 770.25 | 6067 | 12031 | 0.5042 | 0.6828 | MN20160304_L02 | C22 |